Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/13319
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Murugesan, Sankaranarayanan | |
dc.contributor.author | Deepa, P. R. | |
dc.date.accessioned | 2023-12-07T15:22:41Z | |
dc.date.available | 2023-12-07T15:22:41Z | |
dc.date.issued | 2023-07 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S2225411023000809?via%3Dihub | |
dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13319 | |
dc.description.abstract | Novel nature of the viral pathogen SARS-CoV-2 and the absence of standard drugs for treatment, have been a major challenge to combat this deadly infection. Natural products offer safe and effective remedy, for which traditional ethnic medicine can provide leads. An indigenous poly-herbal formulation, Kabasura Kudineer from Siddha system of medicine was evaluated here using a combination of computational approaches, to identify potential inhibitors against two anti-SARS-CoV-2 targets – post-fusion Spike protein (structural protein) and main protease (Mpro, non-structural protein). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Pharmacy | en_US |
dc.subject | Iddha medicine | en_US |
dc.subject | Kabasura kudineer | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | Molecular docking | en_US |
dc.subject | Post fusion spike protein | en_US |
dc.title | In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation – Targeting Mpro and pan-coronavirus post-fusion Spike protein | en_US |
dc.type | Article | en_US |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.